Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections
This study evaluates the frequency of terminal disclaimers filed by drug patent holders to obviate obviousness-type double patenting rejections associated with drug patent thickets.
Authors
- Bernard Chao
- S. Sean Tu (ORCID: https://orcid.org/0000-0003-0391-8186)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
Institutions
- West Virginia University (US)
- Brigham and Women's Hospital (US)
- University of Denver (US)
Publication Details
- Journal
- JAMA
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1001/jama.2024.14350
- Citations
- 2
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 2.26